The membrane-type-matrix metalloproteinase/matrix metalloproteinase- 2/tissue inhibitor of metalloproteinase-2 system in periprosthetic connective-tissue remodelino in loose total-hip prostheses

Laboratory Investigation

Volumn 78, Issue 6, 1998, Pages 735-742

  Takagi, Michiaki ^a   Santavirta, Seppo ^d   Ida, Hideo ^a   Ishii, Masaji ^b   Akimoto, Kazumi ^c   Saotome, Koichi ^c   Konttinen, Yrjö T ^d,e  

^a YAMAGATA UNIVERSITY   (Japan)

^b YAMAGATA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^c DOKKYO MEDICAL UNIVERSITY   (Japan)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ADULT; AGED; ARTICLE; BIOCOMPATIBILITY; CLINICAL ARTICLE; CONNECTIVE TISSUE; ENDOPROSTHESIS LOOSENING; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FEMALE; FOREIGN BODY REACTION; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; TISSUE DISTRIBUTION; TOTAL HIP PROSTHESIS;

AGED; CONNECTIVE TISSUE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GELATINASES; HIP PROSTHESIS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSTHESIS FAILURE; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSCRIPTION, GENETIC;

EID: 0031799191     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Ailenberg M and Silverman M (1996). Cellular activation of mesangial gelatinase A by cytochalasin D is accompanied by enhanced mRNA expression of both gelatinase A and its membrane associated gelatinase A activator (MT-MMP). Biochem J 313:879-884.
2. Aimes RT and Quigley JP (1995). Matrix metalloproteinase-2 is an interstitial collagenase. J Biol Chem 270:5872-5876.
3. Chambers TJ, Darby JA, and Fuller K (1985). Mammalian collagenase predispose bone surface to osteoclastic bone resorption. Cell Tissue Res 241:671-675.
4. Chomczynski P and Sacchi N (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
5. Collier IE, Wilhelm SM, and Eisen AZ (1988). H-ras oncogene transformed human bronchial epithelial cells (TBE-1) secrete a single metalloproteinase capable of degrading basement membrane collagen. J Biol Chem 263:6579-6587.
6. Drake FH, Dodds RA, James IE, Connor JR, Debouck C, Richardson S, Lee-Rykaczewski E, Coleman L, Rieman D, Barthlow R, Hasting G, and Gowen M (1996). Cathepsin K, but not Cathepsin B, L, or S, is abundantly expressed in human osteoclast. J Biol Chem 271:12511-12516.
7. Fujimoto N and Iwata K (1994). Enzyme immunoassays for matrix metalloproteinases and their inhibitors. Connect Tissue 26:237-244.
8. Gelb BD, Shi GP, Chapman HA, and Desnick RJ (1996). Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273:1236-1238.
9. Goldring SR, Schiller AL, Roelke M, Rourke CM, O'Neil DA, and Harris WH (1983). The synovial-like membrane at the bone-cement interface in loose total hip replacement and its proposed role in bone lysis. J Bone Joint Surg Am 65:575-584.
10. Goldring SR, Jasty M, Roelke MS, Rourke CM, Bringhurst FR, and Harris WH (1986). Formation of the synovial-like membrane at the bone cement interface: Its role in bone resorption and implant loosening after total hip replacement. Arthritis Rheum 29:836-842.
11. Harris WH, Schiller AL, Scholler JM, Freiberg RA, and Scott R (1976). Extensive localized bone resorption in the femur following total hip replacement. J Bone Joint Surg Am 58:612-618.
12. Haynes DR, Rogers SD, Hay S, Pearcy MJ, and Howie DW (1993). The differences in toxicity and release of bone-resorbing mediators induced by titanium and cobalt-chromium-alloy wear particles. J Bone Joint Surg Am 75: 825-834.
13. Hill PA, Murphy G, Docherty AJ, Hembry RM, Millican TA, Reynolds JJ, and Meikle MC (1994). The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts. J Cell Sci 107:3055-3064.
14. Holliday LS, Welgus HG, Fliszar CJ, Veith GM, Jeffrey JJ, and Gluck SL (1997). Initiation of osteoclast bone resorption by interstitial collagenase. J Biol Chem 272:22053-22058.
15. Horowitz SM, Doty SB, Lane JM, and Burstein AH (1993). Studies of the mechanism by which the mechanical failure of polymethylmethacrylate leads to bone resorption. J Bone Joint Surg Am 75:802-813.
16. Howie DW, Haynes DR, Rogers SD, McGee MA, and Pearcy MJ (1993). The response to particulate debris (review). Orthop Clin North Am 24:571-581.
17. Hsu SM, Raine L, and Fanger H (1981). Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedure. J Histochem Cytochem 29:577-580.
18. Ishiguro N, Ito T, Kurokouchi K, Iwahori Y, Nagaya I, Hasegawa Y, and Iwata H (1996). mRNA expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in interface tissue around implants in loosening total hip arthroplasty. J Biomed Mater Res 32:611-617.
19. Jasty M, Maloney WJ, Bragdon CR, Haire T, and Harris WH (1990). Histomorphological studies of the long term skeletal response to well fixed cemented femoral components. J Bone Joint Surg Am 72:1220-1229.
20. Jiraneck WA, Machado M, Jasty M, Jevsevar D, Wolfe HJ, Goldring SR, Goldberg M, and Harris WH (1993). Production of cytokines around loosened cemented acetabular components. J Bone Joint Surg Am 75:863-879.
21. Kim KJ, Rubash H, Wilson SC, D'Antonio JA, and McClain EJ (1993). A histologic and biochemical comparison of the interface tissues in cementless and cemented hip prostheses. Clin Orthop 287:142-152.
22. Knäuper V, Will H, Lopez-Otin C, Smith B, Atkinson SJ, Stanton H, Hembry RM, and Murphy G (1996). Cellular mechanisms for human procollagenase-3 (MMP-13) activation: Evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme. J Biol Chem 271:17124-17131.
23. Konttinen YT, Kurvinen H, Takagi M, Michelson JE, Ekulund KK, Nordsletten L, Buø L, Aasen AO, and Santavirta S (1996). IL-1 and collagenase around loose total hip prosthesis. Clin Exp Rheumatol 14:255-262.
24. Konttinen YT, Xu J-W, and Pätiälä H (1997). Cytokines in aseptic loosening of total hip replacement. Curr Orthop 11:40-47.
25. +-ATPase. J Clin Invest 93:2311-2318.
26. Malone JD, Teitelbaum SL, Griffin GL, Senior RM, and Kahn AJ (1982). Recruitment of osteoclast precursors by purified bone matrix components. J Cell Biol 92:227-230.
27. Maloney WJ, Smith RL, Castro F, and Schurman DJ (1993). Fibroblast response to metallic debris in vitro: Enzyme induction, cell proliferation and toxicity. J Bone Joint Surg Am 75:835-844.
28. Miyazaki T, Sato M, Murata Y, Maeda K, and Seo H (1995). Factors present in sera from patients on long term hemodialysis increase mRNA for collagenase and stromelysin in synovial cells. Am J Nephrol 15:48-56.
29. Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, and Okada Y (1997). Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix molecules. J Biol Chem 272:2446-2451.
30. Pei D and Weiss SJ (1994). Transmembrane-deletion mutants of the membrane type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix degrading activity. J Biol Chem 271:9135-9140.
31. Santavirta S, Konttinen YT, Bergroth V, Eskola A, Talloth K, and Lindholm TS (1990). Aggressive granulomatous lesions associated with hip arthroplasty: Immunopathological studies. J Bone Joint Surg Am 72:252-258.
32. Santavirta S, Konttinen YT, Hoikka V, and Eskola A (1991). Immunopathological response to loose cementless acetabular components. J Bone Joint Surg Br 73:38-42.
33. Santavirta S, Sorsa T, Konttinen YT, Saari H, Eskola A, and Eisen AZ (1993). Role of mesenchymal collagenase in the loosening of total hip prostheses. Clin Orthop 290:206-215.
34. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, and Seiki M (1994). A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370:61-65.
35. Sepper R, Konttinen YT, Sorsa T, and Koski H (1994). Gelatinolytic and type IV collagenolytic activity in bronchiectasis. Chest 106:1129-1133.
36. Stetler-Stevenson WG, Brown PD, Onisto M, Levy AT, and Liotta LA (1990). Tissue inhibitor of metalloproteinase-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem 265:13933-13938.
37. Strongin AY, Collier I, Bannikov G, Marner BL, Grant GA, and Goldberg GI (1995). Mechanism of cell surface activation of 72-kDa type IV collagenase: Isolation of the activated form of the membrane metalloproteinase. J Biol Chem 270:5331-5338.
38. Takagi M (1996). Neutral proteinases and their inhibitors in the loosening of total hip prostheses (review). Acta Orthop Scand 67(Suppl 271):1-29.
39. Takagi M, Konttinen YT, Santavirta S, Sorsa T, Eisen AZ, Nordsletten AZ, and Suda A. (1994a). Extracellular matrix metalloproteinases around loose total hip prostheses. Acta Orthop Scand 65:281-286.
40. Takagi M, Konttinen YT, Lindy O, Sorsa T, Kurvinen H, Suda A, and Santavirta S. (1994b). Gelatinase/type IV collagenases in the loosening of total hip replacement endoprosthesis. Clin Orthop 306:136-144.
41. Takagi M, Konttinen YT, Kemppinen P, Sorsa T, Tschesche H, Bläser J, Suda A, and Santavirta S (1995). Tissue inhibitor of matrix metalloproteinases-1 and collageno- and gelatinolytic potential in loose THR endoprostheses. J Rheumatol 22:2285-2290.
42. Tezuka K, Nemoto K, Tezuka Y, Sato T, Ikeda Y, Kobori M, Kawashima H, Eguchi H, Hakeda Y, and Kumegawa M (1994). Identification of matrix metalloproteinase 9 in rabbit osteoclast. J Biol Chem 269:15006-15009.
43. Towbin H, Staehelin T, and Gorden J (1974). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354.
44. Väänänen HK (1993). Mechanism of bone turnover. Ann Med 25:353-359.
45. Wang AM, Doyle MV, and Mark DF (1989). Quantification of mRNA by the polymerase chain reaction. Proc Natl Acad Sci USA 86:9717-9721.
46. Yokohama Y, Matsumoto T, Hirakawa M, Fujimoto N, Imai K, and Okada Y (1995). Production of matrix metalloproteinases at the bone-implant interface in loose total hip replacements. Lab Invest 72:899-911.